On June 10, 2025, Pacira BioSciences, Inc. held its Annual Meeting where stockholders approved an increase of 2.5 million shares in the Amended and Restated 2011 Stock Incentive Plan, and also elected three directors and ratified KPMG as auditors for 2025. The meeting involved voting on several key proposals, including executive compensation and the frequency of advisory votes.